Early outcomes of transcatheter arterial embolization using imipenem/cilastatin for plantar fasciitis refractory to conservative therapy.
Rozil Gandhi, Mohal Banker
https://pubmed.ncbi.nlm.nih.gov/38281074/Actively Recruiting
Led by IR Centers · Updated on 2025-02-03
10
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the safety and feasibility of using Lipiodol ethiodized oil as an investigational embolic agent to treat pain caused by plantar fasciitis. This study focuses on a minimally invasive procedure called plantar fascia embolization PFE, aiming to reduce inflammation and pain in the heel area. The study will assess changes in pain levels and foot function over a six-month period following treatment. Participants will receive plantar fascia embolization using Lipiodol, which targets the blood vessels in the plantar fascia to reduce inflammation and pain. This study involves a single intervention group receiving this treatment. The procedure is designed to be minimally invasive and is administered once during the study period. During the study, participants will be monitored for changes in pain using the Visual Analog Scale VAS and improvements in foot function using the Foot and Ankle Ability Measure FAAM. Researchers will also watch for any side effects or safety concerns related to the treatment. The follow-up period lasts six months, allowing for thorough assessment of outcomes and participant well-being throughout the study.
CONDITIONS
Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis
S
Sindhuja Kommidi Clinical Research Coordinator, MS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
IR Centers
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Investigational Embolization Procedure | Current Standard Non-surgical Care |
|---|---|---|
| What it is | A minimally invasive procedure in which an interventional radiologist injects Lipiodol to selectively embolize abnormal neovessels in the plantar fascia, aiming to reduce inflammation and heel pain. | A combination of non-surgical treatments such as physical therapy, stretching exercises, use of orthotic devices or heel pads, anti-inflammatory medications, and activity modification, provided as first-line care for plantar fasciitis before considering procedures. |
| Primary use | Used to reduce persistent heel pain in adults with plantar fasciitis who have not improved after at least 6 weeks of non-surgical therapy. | Prescribed for initial management to help decrease pain and improve function in people with plantar fasciitis. |
| How it is given or performed | Procedure is typically performed with image guidance, involving catheterization of arteries supplying the plantar fascia, followed by injection of Lipiodol to block abnormal neovessels. | Physical therapy involves in-person sessions guided by a clinician and home exercise programs. Orthoses and heel pads are fitted by healthcare professionals. Medications are taken orally or topically as recommended. |
| Evidence status | Clinical studies have reported reduction in heel pain following arterial embolization in patients with chronic plantar fasciitis not responsive to conservative measures, but long-term and large-scale evidence remains limited. | Non-surgical options are supported by multiple randomized studies and guidelines. Most patients show pain improvement with regular use of stretching, orthoses, and anti-inflammatory medications. |
| Important limitations | Embolization is a minimally invasive vascular procedure that may carry risks such as bleeding, infection, or damage to surrounding tissues. There is limited evidence from small or single-center studies, and long-term outcomes are not yet fully known. | Conservative treatments may require several months for significant pain relief and are not effective for all cases. Some patients may experience recurring symptoms or require escalation to procedural options if pain persists. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single procedure with follow-up assessments up to 6 months
Participants receive plantar fascia embolization using Lipiodol (ethiodized oil) to treat heel pain caused by plantar fasciitis.
1 procedure visit and multiple follow-up visits over 6 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Rozil Gandhi, Mohal Banker
https://pubmed.ncbi.nlm.nih.gov/38281074/Marc Sapoval, Charles Querub, Helena Pereira...
https://pubmed.ncbi.nlm.nih.gov/38102013/Takahide Sasaki, Masahiko Shibuya, Koichi Miyazaki...
https://pubmed.ncbi.nlm.nih.gov/39089905/IR Centers
Lead Sponsor